For STAT, Ed Silverman reports on the former presidential candidate Bernie Sanders’ ongoing fight against pharmaceutical companies. Sanders sent Ariad Pharmaceuticals a letter asking for a plethora of data that might explain a string of “staggering” and “outrageous” price hikes for an expensive cancer treatment.
